Skuldtech provides transcriptomic services based on its over 13 years experience in gene expression technologies, sequencing, qRT-PCR, and bioinformatic data analysis.
Skuldtech has been founded in 1999 to provide life science actors with transcriptomic analyses based on sequencing treatment. Since that date, the company has developed specific bioinformatic and biostatistical programs and databases to treat and to analyze all types of transcriptomic sequenced data files. Skuldtech has also developed specific biostatistical algorithms to treat and analyze qRT-PCR data files.
Hence, Skuldtech provides its transcriptomic expertise and services to perform analyses related to:
Digital Gene Expression (DGE), a quantitative and qualitative overview of mRNA population,
RNA-seq, a qualitative overview of coding and non-coding RNA population and molecular
rearrangements associated like splicing,
Small RNA, with miRNA and the large family of short and non-coding RNA,
Real-Time PCR, with high throughput reactions up to 20,000 per day..
Bioinformatics & Biostatistics
Treatment and analysis of transcriptomic data through proprietary bioinformatic software and
Comparison of transcriptomic libraries with Skuldtech gene profiles database containing more
than 1700 transcriptomes,
Biostatistical analyses through proprietary algorithms.
Skuldtech has recently worked for a veterinary pharmaceutical company to study by qRT-PCR the gene expression level of a specific biomarker in blood. This study related to the dose and the kinetic of a new treatment.
In 2011, the company has been chosen by the RegulBASS project teams (ANR grant) to realize 24 transcriptomes in parallel. The results have been presented in a scientific poster.
Concerning miRNA expression profiles, Skuldtech has collaborated with Professor Hamamah from the Institute For Research in Biotherapy (Montpellier hospital, France) to analyze miRNAome in human matured cumulus-oocyte complex.
Since 1999, Skuldtech has collaborated with several scientific teams and has established partnerships, which have led to a large panel of publications.
If you require any additional information concerning the services provided by our company,
please contact our commercial department: +33(0)467 419 748.
Skuldtech is specialized in the discovery of
new Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics
associated with new treatments, especially in
cancer, neurodegenerative and infectious diseases.